Böhm, S., Mauz-Körholz, C., Wustrau, K., Pachlopnik Schmid, J., Prader, S., Ahlmann, M., . . . Ehl, S. (2024). Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: Etoposide is better than its reputation. Blood, 143(10), . https://doi.org/10.1182/blood.2023022281
Chicago Style (17th ed.) CitationBöhm, Svea, et al. "Survival in Primary Hemophagocytic Lymphohistiocytosis, 2016 to 2021: Etoposide Is Better than Its Reputation." Blood 143, no. 10 (2024). https://doi.org/10.1182/blood.2023022281.
MLA (9th ed.) CitationBöhm, Svea, et al. "Survival in Primary Hemophagocytic Lymphohistiocytosis, 2016 to 2021: Etoposide Is Better than Its Reputation." Blood, vol. 143, no. 10, 2024, https://doi.org/10.1182/blood.2023022281.
Warning: These citations may not always be 100% accurate.